NASDAQ, MNKD - Mannkind Corp
Unless the context requires otherwise, the words ?MannKind,? ?we,? ?company,?
?us? and ?our? refer to MannKind Corporation and its subsidiary.
OVERVIEW
MannKind Corporation is a biopharmaceutical company focused on the discovery,
development and commercialization of therapeutic products for diseases such as
diabetes and cancer. Our lead investigational product candidate, the
Technosphere Insulin System, is currently in Phase 3 clinical trials in the
United States, Europe and Latin America to study its safety and efficacy in the
treatment of diabetes. This dry powder therapy consists of our proprietary
Technosphere particles onto which insulin molecules are loaded. These loaded
particles are then aerosolized and inhaled into the deep lung using our
proprietary MedTone inhaler. We believe that the performance characteristics,
unique kinetics, convenience and ease of use of our Technosphere Insulin System
may have the potential to change the way diabetes is treated. ...
Read SEC Filing on NASDAQ.com »